Ovarian Cancer Coverage from Every Angle

Isabelle Ray-Coquard, MD, PhD, on the Safety of Combination Regimens With Bevacizumab

Posted: Monday, September 30, 2019

Does the combination of a PARP inhibitor and bevacizumab require special monitoring regarding safety?

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.